Rise in incidence of ophthalmic diseases is the factor holding the responsibility of growth of ophthalmology PACS market.
An ophthalmology PACS lets eye doctors as well as clinicians digitally access, manage, store, and view eye scans, images, and reports from various ophthalmic imaging modalities such as ultrasound biomicroscopy, fundus imaging, etc. AI is being integrated with PACS these days to raise the precision quotient.
The companies operating in the ophthalmology PACS market are adopting incorporation of efficient net batch normalizations (BNs) in order to grade diabetic retinopathy severity levels from the fundus images. They are also trying to work toward unleashing the cost-effective ophthalmology PACS to cater to the under-developed economies.
Ophthalmology PACS (Picture Archiving and Communication System) means a medical imaging technology especially designed for storing, retrieving, and distributing ophthalmic images such as retinal scans, and fundus photographs, along with patient data.
The high-resolution ophthalmic imaging systems mentioned above are altering the way surgeons utilize diagnostic methods. Optical coherence tomography (OCT), fundus autofluorescence imaging, and fluorescein angiography make available information regarding pathogens related to various ocular diseases.
These imaging techniques play a vital role in decision-making for new-fangled treatment approaches such as intravitreal injections to treat posterior segment eye diseases.
Cloud-based teleradiology solutions allow remote consultations and image sharing. Integration of analytics and AI makes provisions for workflow improvements and predictive diagnostics.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Ophthalmic diseases include cataract, age-related macular degeneration, glaucoma, and diabetic retinopathy. The other disorders include strabismus and amblyopia. Presbyopia (loss of ability of focusing up close, inability of reading words in book, and needing to hold newspaper away in order to see clearly) occurs between 40 and 50 years of age.
Ophthalmology PACS (Picture Archiving and Communication System) helps in the storage, retrieval, management, and sharing ophthalmology images and the other patient data.
As per the WHO, close to 2.2 billion individuals have a distance or near vision impairment worldwide. It further states that 1 billion of them could have vision impairment prevented/cured if diagnosed at the earliest.
Need to combat ophthalmic diseases is thus driving the ophthalmology PACS market growth.
Positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), computed tomography (CT), sonography, and digital mammography are the diagnostic imaging modalities into existence.
The advancements in diagnostic imaging modalities include augmented and artificial intelligence, augmented and virtual reality in conjunction with 3D imaging, portable and wearable scanners, and likewise.
Medical scientists are effectively adapting AI, VR, wearable computers, and the other technological advances in order to enhance healthcare. Computers are capable of simulating real-world situations such that humans are provided with diverse perspectives and new insights to go beyond human sensory perception.
Virtual reality platforms help surgeons as they prepare to conduct procedures in order to treat congenital heart defects. These patient-specific surgical views lessen the likelihood of encountering the unexpected conditions happening during surgery.
In July 2021, Intelerad Medical Systems partnered with LifeBridge Health in order to provide cloud-based medical imaging managed services.
Continual advancements in diagnostic imaging modalities are thus expanding the ophthalmology PACS market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest ophthalmology PACS market analysis, North America led the ocular imaging platform in 2023 and the scenario is expected to persist during the forecast period. This is attributed to the U.S. witnessing higher healthcare expenditure, thereby resulting in stronger healthcare infrastructure.
Moreover, conducive government policies that support digitization of healthcare records are bolstering the adoption of PACS solutions around the world. The retinal clinics in the U.S. are upgrading their imaging systems on continuous basis.
In November 2020, EyeMD EMR Healthcare Systems, Inc. introduced a comprehensive EMR, PM, and PACS system called EyeMD EMR 2.0 at the American Academy of Ophthalmology (AAO) Virtual Conference that took place from November 13 to 15, 2020.
Asia Pacific’s significant ophthalmology PACS market share is ascribed to growing investment in modernization of ophthalmologic sector by countries such as India and China. Growing medical tourism over here is another factor fueling the demand for ophthalmology PACS.
The key participants in the ophthalmology PACS market are engaging in inorganic modes of expansion for strengthening their position. For instance, in April 2021, Carl Zeiss Meditec acquired Katalyst Surgical and Kogent Surgical for expanding its business and providing improved surgical solutions, especially for ophthalmic medical conditions.
Carl Zeiss Meditec AG, Topcon Corporation, Heidelberg Engineering GmbH, Sonomed Escalon, Visbion Ltd, EyePACS, VersaSuite, Merative L.P., Inventia Life Science, and ScImage Inc are some of the key players covered in the ophthalmology PACS market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 167.8 Mn |
| Market Forecast (Value) in 2034 | US$ 359.8 Mn |
| Growth Rate (CAGR) | 7.3% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 167.8 Mn in 2023
It is projected to grow at a CAGR of 7.3% from 2024 to 2034
Growing prevalence of ophthalmic diseases and technological advancements regarding diagnostic imaging modalities
Ophthalmologic clinics segment accounted for the largest share in 2023
North America was the dominant region in 2023
Carl Zeiss Meditec AG, Topcon Corporation, Heidelberg Engineering GmbH, Sonomed Escalon, Visbion Ltd, EyePACS, VersaSuite, Merative L.P., Inventia Life Science, and ScImage Inc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Ophthalmology PACS Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Ophthalmology PACS Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Ophthalmology PACS Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Integrated PACS
6.3.2. Standalone PACS
6.4. Market Attractiveness Analysis, by Product Type
7. Global Ophthalmology PACS Market Analysis and Forecast, by Delivery Model
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Delivery Model, 2020-2034
7.3.1. On-premise
7.3.2. Web/cloud-based
7.4. Market Attractiveness Analysis, by Delivery Model
8. Global Ophthalmology PACS Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Ophthalmology Clinics
8.3.3. Ambulatory Surgery Centers
8.3.4. Others (Eye Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Ophthalmology PACS Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Ophthalmology PACS Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2020-2034
10.3.1. Integrated PACS
10.3.2. Standalone PACS
10.4. Market Value Forecast, by Delivery Model, 2020-2034
10.4.1. On-premise
10.4.2. Web/cloud-based
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Ophthalmology Clinics
10.5.3. Ambulatory Surgery Centers
10.5.4. Others (Eye Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Delivery Model
10.7.3. By End-user
10.7.4. By Country
11. Europe Ophthalmology PACS Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2020-2034
11.3.1. Integrated PACS
11.3.2. Standalone PACS
11.4. Market Value Forecast, by Delivery Model, 2020-2034
11.4.1. On-premise
11.4.2. Web/cloud-based
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Ophthalmology Clinics
11.5.3. Ambulatory Surgery Centers
11.5.4. Others (Eye Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Delivery Model
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Ophthalmology PACS Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2020-2034
12.3.1. Integrated PACS
12.3.2. Standalone PACS
12.4. Market Value Forecast, by Delivery Model, 2020-2034
12.4.1. On-premise
12.4.2. Web/cloud-based
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Ophthalmology Clinics
12.5.3. Ambulatory Surgery Centers
12.5.4. Others (Eye Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Delivery Model
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Ophthalmology PACS Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2020-2034
13.3.1. Integrated PACS
13.3.2. Standalone PACS
13.4. Market Value Forecast, by Delivery Model, 2020-2034
13.4.1. On-premise
13.4.2. Web/cloud-based
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Ophthalmology Clinics
13.5.3. Ambulatory Surgery Centers
13.5.4. Others (Eye Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Delivery Model
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Ophthalmology PACS Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2020-2034
14.3.1. Integrated PACS
14.3.2. Standalone PACS
14.4. Market Value Forecast, by Delivery Model, 2020-2034
14.4.1. On-premise
14.4.2. Web/cloud-based
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Ophthalmology Clinics
14.5.3. Ambulatory Surgery Centers
14.5.4. Others (Eye Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Delivery Model
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Carl Zeiss Meditec AG
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Topcon Corporation
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Heidelberg Engineering GmbH
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Sonomed Escalon
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Visbion Ltd
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. EyePACS
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. VersaSuite
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Merative L.P.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Inventia Life Science
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. ScImage Inc
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Ophthalmology PACS Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 02: Global Ophthalmology PACS Market Size (US$ Mn) Forecast, by Delivery Model, 2020-2034
Table 03: Global Ophthalmology PACS Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Ophthalmology PACS Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Ophthalmology PACS Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Ophthalmology PACS Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 07: North America Ophthalmology PACS Market Size (US$ Mn) Forecast, by Delivery Model, 2020-2034
Table 08: North America Ophthalmology PACS Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Ophthalmology PACS Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Ophthalmology PACS Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 11: Europe Ophthalmology PACS Market Size (US$ Mn) Forecast, by Delivery Model, 2020-2034
Table 12: Europe Ophthalmology PACS Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Ophthalmology PACS Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Ophthalmology PACS Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 15: Asia Pacific Ophthalmology PACS Market Size (US$ Mn) Forecast, by Delivery Model, 2020-2034
Table 16: Asia Pacific Ophthalmology PACS Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Ophthalmology PACS Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Ophthalmology PACS Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 19: Latin America Ophthalmology PACS Market Size (US$ Mn) Forecast, by Delivery Model, 2020-2034
Table 20: Latin America Ophthalmology PACS Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Ophthalmology PACS Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Ophthalmology PACS Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 23: Middle East & Africa Ophthalmology PACS Market Size (US$ Mn) Forecast, by Delivery Model, 2020-2034
Table 24: Middle East & Africa Ophthalmology PACS Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Ophthalmology PACS Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Ophthalmology PACS Market Revenue (US$ Mn), by Product Type, 2023
Figure 03: Global Ophthalmology PACS Market Value Share, by Product Type, 2023
Figure 04: Global Ophthalmology PACS Market Revenue (US$ Mn), by Delivery Model, 2023
Figure 05: Global Ophthalmology PACS Market Value Share, by Delivery Model, 2023
Figure 06: Global Ophthalmology PACS Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global Ophthalmology PACS Market Value Share, by End-user, 2023
Figure 08: Global Ophthalmology PACS Market Value Share, by Region, 2023
Figure 09: Global Ophthalmology PACS Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Ophthalmology PACS Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 11: Global Ophthalmology PACS Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Ophthalmology PACS Market Value Share Analysis, by Delivery Model, 2023 and 2034
Figure 13: Global Ophthalmology PACS Market Attractiveness Analysis, by Delivery Model, 2024-2034
Figure 14: Global Ophthalmology PACS Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Ophthalmology PACS Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Ophthalmology PACS Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Ophthalmology PACS Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Ophthalmology PACS Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Ophthalmology PACS Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Ophthalmology PACS Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Ophthalmology PACS Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 22: North America Ophthalmology PACS Market Value Share Analysis, by Delivery Model, 2023 and 2034
Figure 23: North America Ophthalmology PACS Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Ophthalmology PACS Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Ophthalmology PACS Market Attractiveness Analysis, by Delivery Model, 2024-2034
Figure 26:North America Ophthalmology PACS Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Ophthalmology PACS Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Ophthalmology PACS Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Ophthalmology PACS Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Ophthalmology PACS Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 31: Europe Ophthalmology PACS Market Value Share Analysis, by Delivery Model, 2023 and 2034
Figure 32: Europe Ophthalmology PACS Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Ophthalmology PACS Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Ophthalmology PACS Market Attractiveness Analysis, by Delivery Model, 2024-2034
Figure 35: Europe Ophthalmology PACS Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Ophthalmology PACS Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Ophthalmology PACS Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Ophthalmology PACS Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Ophthalmology PACS Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 40: Asia Pacific Ophthalmology PACS Market Value Share Analysis, by Delivery Model, 2023 and 2034
Figure 41: Asia Pacific Ophthalmology PACS Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Ophthalmology PACS Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Ophthalmology PACS Market Attractiveness Analysis, by Delivery Model, 2024-2034
Figure 44: Asia Pacific Ophthalmology PACS Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Ophthalmology PACS Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Ophthalmology PACS Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Ophthalmology PACS Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Ophthalmology PACS Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 49: Latin America Ophthalmology PACS Market Value Share Analysis, by Delivery Model, 2023 and 2034
Figure 50: Latin America Ophthalmology PACS Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Ophthalmology PACS Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Ophthalmology PACS Market Attractiveness Analysis, by Delivery Model, 2024-2034
Figure 53: Latin America Ophthalmology PACS Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Ophthalmology PACS Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Ophthalmology PACS Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Ophthalmology PACS Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Ophthalmology PACS Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 58: Middle East & Africa Ophthalmology PACS Market Value Share Analysis, by Delivery Model, 2023 and 2034
Figure 59: Middle East & Africa Ophthalmology PACS Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Ophthalmology PACS Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Ophthalmology PACS Market Attractiveness Analysis, by Delivery Model, 2024-2034
Figure 62: Middle East & Africa Ophthalmology PACS Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Ophthalmology PACS Market
